FMP

FMP

Blogs by Tony Dante

Jul 10, 2025 7:00 PM - Tony Dante

McDonald's Corporation (NYSE:MCD) Executive Sells Shares; Stock Rises on Analyst Upgrades

On July 10, 2025, Flatley Edith Morgan, the Executive Vice President and Global Chief Marketing Officer of McDonald's Corporation (NYSE:MCD), sold 1,000 shares of the company's common stock at $300 each. This transaction leaves her with about 8,857.56 shares. McDonald's, a leading player in the fast...

blog post title

Jul 10, 2025 3:00 PM - Tony Dante

Vertiv Holdings Co (NYSE:VRT) Faces Competitive Challenges and Market Fluctuations

Vertiv Holdings Co (NYSE:VRT) is a prominent player in the infrastructure sector, focusing on cooling and power systems for data centers. On July 10, 2025, Evercore ISI updated its rating for Vertiv to "Outperform," with the stock priced at approximately $120.31. Despite this positive rating, the ac...

blog post title

Jul 10, 2025 2:05 PM - Tony Dante

Deutsche Bank Maintains "Buy" Rating for WPP PLC Amid Leadership Changes

On July 10, 2025, Deutsche Bank maintained its "Buy" rating for WPP PLC (NYSE:WPP), even though the stock's action was "hold." At that time, WPP's stock price was $29.36. Deutsche Bank also adjusted WPP's price target, lowering it from 740 GBp to 550 GBp. This decision comes amid significant changes...

blog post title

Jul 10, 2025 10:00 AM - Tony Dante

ConAgra Brands Inc. (NYSE:CAG) Faces Earnings Challenges Amid Market Pressures

ConAgra Brands Inc. (NYSE:CAG) is a well-known player in the packaged food industry, recognized for its popular brands like Slim Jim, Healthy Choice, and Hunt's. The company operates in a competitive market, facing rivals such as General Mills and Kraft Heinz. On July 10, 2025, ConAgra reported its ...

blog post title

Jul 9, 2025 6:00 PM - Tony Dante

Theratechnologies Inc. (NASDAQ:THTX) Earnings Report Highlights

Theratechnologies Inc. (NASDAQ:THTX) is a commercial-stage biopharmaceutical company. It focuses on developing and commercializing innovative therapies. The company recently reported its earnings for the second quarter of 2025. Despite challenges, THTX continues to make strides in the biopharmaceuti...

blog post title

Jul 9, 2025 4:00 PM - Tony Dante

Conagra Brands, Inc. (NYSE: CAG) Analysts Adjust Price Targets Amid Market Conditions

Conagra Brands, Inc. (NYSE: CAG) is a prominent name in the North American consumer packaged goods food industry. The company boasts a diverse portfolio of well-known brands, including Birds Eye, Duncan Hines, and Slim Jim. Conagra operates through four main segments: Grocery & Snacks, Refrigerated ...

blog post title

Jul 9, 2025 1:00 AM - Tony Dante

Levi Strauss & Co. (NYSE:LEVI) Earnings Preview and Strategic Moves

Levi Strauss & Co. (NYSE:LEVI) is a renowned name in the apparel industry, known for its iconic denim products. As a major player in the Zacks Retail - Apparel and Shoes industry, Levi has consistently outperformed earnings estimates, showcasing its resilience and strategic prowess. The company is s...

blog post title

Jul 8, 2025 9:05 PM - Tony Dante

Thermo Fisher Scientific Inc. (NYSE:TMO) Faces Downgrade but Shows Growth Potential

Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader in serving science, providing innovative solutions for the pharmaceutical, biotechnology, and bioproduction sectors. The company is known for its comprehensive range of products and services that support research, diagnostics, and manufactu...

blog post title

Jul 8, 2025 12:00 PM - Tony Dante

Enovix Corporation's Strategic Milestones and Market Performance

Enovix Corporation (NASDAQ:ENVX) is a prominent player in the high-performance battery technology sector. Known for its innovative approach, Enovix has recently made headlines with the launch of its AI-1™ platform, a silicon-anode smartphone battery designed to support advanced mobile AI functions. ...

blog post title

Jul 7, 2025 8:00 AM - Tony Dante

Nurix Therapeutics, Inc. (NASDAQ:NRIX) Earnings Preview: Key Financial Insights

Nurix Therapeutics, Inc. (NASDAQ:NRIX) is a biotechnology company focused on developing therapies that modulate protein levels. As it prepares to release its quarterly earnings on July 10, 2025, Wall Street anticipates an earnings per share (EPS) of -$0.72 and revenue of approximately $16.3 million....

blog post title